Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim

NCT01752907 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01752907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01752907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Completed
Start date
January 17, 2013
Completion date
December 15, 2014
Enrollment
304 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer